C12N 2740/16061
Methods of inactivation or attenuation
C12N2740/16061 (Methods of inactivation or attenuation) appears on 129 US grants and 158 published applications in this corpus.
Search patents in C12N- Granted patents
- 129
- Published applications
- 158
- Assignees
- 97
- Inventors
- 251
- Latest grant
- 25 Mar 2025
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1988 | 1 | 0 |
| 1989 | 1 | 0 |
| 1990 | 0 | 0 |
| 1991 | 0 | 0 |
| 1992 | 0 | 0 |
| 1993 | 2 | 0 |
| 1994 | 2 | 0 |
| 1995 | 0 | 0 |
| 1996 | 3 | 0 |
| 1997 | 6 | 0 |
| 1998 | 6 | 0 |
| 1999 | 4 | 0 |
| 2000 | 8 | 0 |
| 2001 | 9 | 0 |
| 2002 | 7 | 11 |
| 2003 | 7 | 9 |
| 2004 | 4 | 4 |
| 2005 | 2 | 9 |
| 2006 | 5 | 8 |
| 2007 | 3 | 8 |
| 2008 | 0 | 5 |
| 2009 | 4 | 7 |
| 2010 | 10 | 10 |
| 2011 | 2 | 6 |
| 2012 | 4 | 9 |
| 2013 | 6 | 2 |
| 2014 | 4 | 3 |
| 2015 | 4 | 6 |
| 2016 | 2 | 10 |
| 2017 | 2 | 6 |
| 2018 | 3 | 25 |
| 2019 | 3 | 2 |
| 2020 | 4 | 4 |
| 2021 | 1 | 4 |
| 2022 | 5 | 1 |
| 2023 | 4 | 3 |
| 2024 | 0 | 4 |
| 2025 | 1 | 2 |
By publication year. Applications have been published since 2001.
Subgroups
Granted patents
Recent patents
- Environmentally compatible detergents for inactivation of lipid-enveloped viruses25 Mar 2025US 12,258,540 B2Takeda Pharmaceutical Company Limited
- Editing of CCR2 receptor gene to protect against HIV infection21 Nov 2023US 11,820,969 B2President and Fellows of Harvard College
- Inducible expression systems18 Jul 2023US RE49,583 E1TET Systems GmbH & Co. KG
- Methods and compositions for generating a deletion library and for identifying a defective interfering particle (DIP)21 Feb 2023US 11,584,931 B2The J. David Gladstone Institutes
- Alkaloids from sponge, scaffolds for the inhibition of human immunodeficiency virus (HIV)3 Jan 2023US 11,541,037 B2King Abdullah University of Science and Technology
- Lentivirus vector with controllable expression of gene of interest, and packaging method therefor4 Sep 2025US 2025/0277232 A1
- Tat-induced crispr/endonuclease-based gene editing7 Aug 2025US 2025/0250562 A1Temple University of the Commonwealth System of Higher Education
- Continuous flow, high throughput apparatus and method for inactivating viruses and pathogens in human plasma24 Oct 2024US 2024/0350691 A1Aphios Corporation
- Methods and compositions for rna-guided treatment of hiv infection2 May 2024US 2024/0139294 A1Temple University of the Commonwealth System of Higher Education
- Editing of ccr5 receptor gene to protect against hiv infection4 Apr 2024US 2024/0110166 A1President and Fellows of Harvard College
Most cited
By later US patents
- Immunizing compositions comprising nucleic acids encoding the HIV-1 matrix protein myristate binding site1,449US 7,718,180 B22010
- Vector and method of use for nucleic acid delivery to non-dividing cells323US 6,013,516 AThe Salk Institute for Biological Studies · 2000
- Use of triplex structure DNA in transferring nucleotide sequences98US 6,682,907 B1Institut Pasteur · 2004
- Photodynamic inactivation of viruses in cell-containing compositions80US 5,232,844 ANew York Blood Center, Inc. · 1993
- Ribonuclease resistant RNA preparation and utilization80US 5,939,262 AAmbion, Inc. · 1999